23 results on '"Sánchez-Ortiga R"'
Search Results
2. POS0125 ASSESSMENT OF THE INFLAMMATORY PROFILE EXPRESSED IN ASYMPTOMATIC HYPERURICEMIA WITH SONOGRAPHIC DEPOSITS, INCLUDING A COMPARISON WITH NORMOURICEMIA AND GOUT
- Author
-
Andrés, M., primary, Peral-Garrido, M. L., additional, Gómez, S., additional, Caño, R., additional, Bermúdez-García, A., additional, Boix, P., additional, Lozano, T., additional, Sánchez-Ortiga, R., additional, Perdiguero, M., additional, Caro-Martínez, E., additional, Ruiz-García, C., additional, Pascual, E., additional, and Francés, R., additional
- Published
- 2024
- Full Text
- View/download PDF
3. AB1243 WHICH IS THE MOST APPROPRIATE SONOGRAPHIC DEFINITION FOR ASYMPTOMATIC HYPERURICEMIA WITH MSU CRYSTAL DEPOSITION?
- Author
-
Peral, M. L., primary, Gomez-Sabater, S., additional, Caño-Alameda, R., additional, Bermúdez-García, A., additional, Lozano, T., additional, Sánchez-Ortiga, R., additional, Perdiguero, M., additional, Caro, E., additional, Ruiz, C., additional, Francés, R., additional, Pascual, E., additional, and Andrés, M., additional
- Published
- 2023
- Full Text
- View/download PDF
4. WHICH IS THE MOST APPROPRIATE SONOGRAPHIC DEFINITION FOR ASYMPTOMATIC HYPERURICEMIA WITH MSU CRYSTAL DEPOSITION?
- Author
-
Peral, M. L., Gomez-Sabater, S., Caño-Alameda, R., Bermúdez-García, A., Lozano, T., Sánchez-Ortiga, R., Perdiguero, M., Caro, E., Ruiz, C., Francés, R., Pascua, E., and Andrés, M.
- Published
- 2023
- Full Text
- View/download PDF
5. Over-expression of vascular endothelial growth factor in pituitary adenomas is associated with extrasellar growth and recurrence
- Author
-
Sánchez-Ortiga R, Sánchez-Tejada L, Moreno-Perez O, Riesgo P, Niveiro M, and Picó Alfonso AM
- Abstract
Some pituitary adenomas (PA) demonstrate aggressive behavior with local invasion and recurrences. Angiogenesis is regarded as an essential step in the formation of solid tumors. The aim of this study is to find out whether angiogenic factors may have information about the aggressiveness of PA that could be useful in determining the frequency of follow-up and whether adjuvant therapy is necessary. In this retrospective descriptive study, we evaluated vascular endothelial growth factors (VEGF) and VEGF receptor (KDR) mRNA expression by RT-PCR analysis on 46 human PA samples. Clinical data, histological subtype and radiologic characteristics were studied to determine the associations between the variables and the pre-operative behavior of the tumor. In addition, we monitored 12 patients without adjuvant post-operative therapies over 46 months after surgery, determining progression of tumor remnants and its association with these markers. VEGF expression correlates with KDR expression (r = 0.40, p = 0.006). VEGF demonstrates different expression between histological subtypes (p = 0.036). The extension at magnetic resonance imaging showed that VEGF expression was related to suprasellar extension (p = 0.007), being expressed more on tumors with extrasellar growth than intrasellar ones (p = 0.008). Our results demonstrate a 27.5 times increased risk of extrasellar growth when VEGF expression exceeds 0.222 normalized copy number (NCN) (p = 0.002). Likewise, tumors with KDR greater than 0.750 NCN had less recurrence-free survival time (p = 0.032). Our results suggest that the expression of VEGF and its receptor could be a marker for poor outcome after partial tumor resection. These data should be considered in future studies evaluating angiogenic factors as therapeutic targets in patients with PA.
- Published
- 2013
6. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness
- Author
-
Sánchez-Tejada L, Sánchez-Ortiga R, Moreno-Pérez O, Montañana CF, Niveiro M, Tritos NA, and Alfonso AM
- Subjects
Pituitary tumor transforming gene protein ,DA ,lactotrophic adenomas ,NFPA ,PRL ,adrenocorticotropic hormone ,Antígeno Ki-67 ,phosphoinositide 3-kinase/Akt pathway ,FFPE ,TT ,Proteína del gen transformador de tumores hipofisarios ,IGF1R ,LT ,Thyroid stimulating hormone ,magnetic resonance imaging ,Insulin-like growth factor 1 receptor ,ROC ,Ki-67 antigen ,null-cell adenomas ,formalin-fixes and paraffin-embedded ,functioning pituitary adenoma ,TSH ,FPA ,GH ,Humanos ,ST ,GT ,real time polymerase chain reaction ,Adenoma hipofisario ,pituitary adenomas ,CT ,MRI ,PA ,gonadotrophic adenomas ,prolactin ,Thyrotrophic adenomas ,RT-PCR ,dopamine agonist ,somatostatin ,pituitary tumor transforming gene ,Humans ,non-functioning pituitary adenoma ,corticotrophic adenomas ,PI3K/Akt ,Receptor del factor de crecimiento insulinoide 1 ,MAPK ,Pituitary adenoma ,ACTH ,receiver operating characteristics ,mitogen-activated protein kinases ,growth hormone ,PTTG ,NC ,SSa - Abstract
INTRODUCTION AND OBJECTIVE: The ability to predict recurrence of pituitary adenoma (PA) after surgery may be helpful to determine follow-up frequency and the need for adjuvant treatment. The purpose of this study was to assess the prognostic capacity of pituitary tumor transforming gene (PTTG), insulin-like growth factor 1 receptor (IGF1R), and Ki-67. MATERIALS AND METHODS: In this retrospective study, the normalized copy number (NCN) of PTIG and IGF1R mRNA was measured using RT-PCR, and the Ki-67 index was measured by immunohistochemistry in 46 PA samples. Clinical data, histological subtype, and radiographic characteristics were collected to assess associations between variables and tumor behavior. Progression of tumor remnants and its association to markers was also studied in 14 patients with no adjuvant treatment after surgery followed up for 46±36 months. RESULTS: Extrasellar tumors had a lower PTTG expression as compared to sellar tumors (0.065 [1st-3rd quartile: 0.000-0.089] NCN vs. 0.135 [0.105-0.159] NCN, p=0.04). IGF1R expression changed depending on histological subtype (p=0.014), and was greater in tumor with remnant growth greater than 20% during follow-up (10.69±3.84 NCN vs. 5.44±3.55 NCN, p=0.014). CONCLUSIONS: Our results suggest that the IGF1R is a more helpful molecular marker than PTTG in PA management. Ki-67 showed no association to tumor behavior. However, the potential of these markers should be established in future studies with standardized methods and on larger samples.
- Published
- 2013
7. A propósito de tres casos. Respuesta a la terapia adyuvante con perclorato potásico en la tirotoxicosis inducida por amiodarona
- Author
-
Arias N, Moreno-Pérez Ó, Boix E, Serrano J, Revert P, González VL, Sánchez-Ortiga R, and Picó AM
- Abstract
INTRODUCTION: Amiodarone-induced thyrotoxicosis (AIT) is a common clinical disorder that may be life threatening and whose clinical manifestations and response to treatment may vary among patients. METHODS: We present three patients treated with amiodarone for atrial fibrillation who developed AIT at least 36 months after beginning the treatment. Thyrotoxicosis worsened the underlying cardiac disorders and was resistant to treatment based on the combination of dexamethasone 8-12 mg/day i.v., thioamides 45 mg/day p.o., beta blockers and potassium perchlorate at doses of 800 to 1000 mg per day p.o. Two of the patients attained sustained euthyroidism after 12 and 32 days of combined treatment, while the third required total thyroidectomy. CONCLUSION: The combination of thioamides with potassium perchlorate is an appropriate form of therapy for AIT in patients resistant to thioamides. The use of this combination should be evaluated in patients with mixed AIT or AIT of unclear etiology.
- Published
- 2011
8. Validation of the human chorionic gonadotropin immunoassay in cerebrospinal fluid for the diagnostic work-up of neurohypophyseal germinomas
- Author
-
González-Sánchez V, Moreno-Pérez O, Pellicer PS, Sánchez-Ortiga R, Guerra RA, Dot MM, and Alfonso AM
- Abstract
BACKGROUND: The measurement of human chorionic gonadotropin (hCG) in cerebrospinal fluid (CSF) is useful for the differential diagnosis of suprasellar lesions. However, the concentrations that prove diagnostic for neurohypophyseal germinoma have not been well defined. In addition, the immunoassays used for such measurements are the same as those applied in serum, and few studies have been performed regarding the validation of such techniques in CSF. The present study aims to apply the Elecsys(®) hCG + ß immunoassay from Roche Diagnostics to measure hCG in CSF, as a useful tool in the diagnosis of neurohypophyseal germinomas in children and young adults. METHODS: Validation of the immunoassay involved calculation of the functional sensitivity and reference values for hCG in CSF in 35 controls in the absence of pregnancy, trophoblastic disease or tumour pathology. For the clinical application study, three patients diagnosed with neurohypophyseal germinoma have been reviewed. RESULTS: The functional sensitivity obtained was 0.4 IU/L. The reference values for hCG in CSF ranged from undetectable values to 0.7 IU/L. The hCG concentrations in CSF in the three studied patients, with confirmed diagnosis of neurohypophyseal germinoma, were 21.1, 32.6 and 23 IU/L, respectively. CONCLUSIONS: The Elecsys® hCG + ß immunoassay from Roche Diagnostics can be used to detect hCG in CSF with high precision. According to our results, CSF-hCG concentrations that exceed the established reference interval (undetectable values to 0.7 IU/L) in the presence of suprasellar lesions and hypophyseal stalk thickening must be considered pathological, establishing the need to exclude the presence of germinoma.
- Published
- 2011
9. Papel de pituitary tumour-transforming gene (PTTG) en los adenomas hipofisarios
- Author
-
Sánchez-Ortiga R, Sánchez Tejada L, Peiró Cabrera G, Moreno-Pérez O, Arias Mendoza N, Aranda López FI, and Picó Alfonso A
- Abstract
The pathogenesis of pituitary tumours is far to be understood. Pituitary transforming tumour gene (PTTG), a gen that induces aneuploidy, genetic instability, cellular proliferation and to stimulate angiogenesis, has been involved in neoplasic transformation and shown overexpressed in many neoplasm as lung, breast, endometrium, thyroid and colon malignant tumours. On the other hand, PTTG has been inconsistently studied in pituitary tumours. The majority of studies have been performed in animals and there is a great variability in the methods used in its determination. The goal of this review is to resume the role of PTTG in tumourogenesis and critically to revise the studies published in humans in order to advance in the knowledge of the pathogenesis of pituitary adenomas and to find clinical useful predictors of the behavior of these tumours.
- Published
- 2010
10. Treatment of Graves' ophthalmopathy with high-dose intravenous methylprednisolone: a comparison of two dosing regimens
- Author
-
Sánchez-Ortiga R, Moreno-Pérez O, González Sánchez V, Arias Mendoza N, Mauri Dot M, Alfayate Guerra R, López Macia A, and Picó Alfonso A
- Abstract
RATIONALE AND OBJECTIVE: The treatment of active moderate-severe Graves' ophthalmopathy (GO) is based on the administration of highdose intravenous glucocorticoids. The present study compares the efficacy and safety of 2 different intravenous methylprednisolone (MTPiv) dosing regimens. MATERIAL AND METHODS: We carry a retrospective descriptive study with sequential sampling of 24 patients (83% females) presenting moderatesevere GO (EUGOGO criteria) and receiving treatment in our center between January 2006 and June 2008. We use 2 dosing regimens: regimen A (12 weeks): 6 doses of 0.5g/week followed by 6 doses of 0.25 g/week, for a cumulative dose of 4.5 g of MTPiv (n=13); and regimen B (16 weeks): 4 cycles of 15 mg/kg, followed by 4 cycles of 7.5mg/kg, for a cumulative dose of 90 mg/kg (range, 4.9-7.4 g) (n=11). Comparisons were made for safety (fasting glucose, cytolysis-cholestasis enzymes, lipid profile) and efficacy data (clinical improvement and recurrence). RESULTS: Mild-moderate liver cytolysis was recorded in four patients, one with associated moderate cholestasis and another with hyperglycemia, leading to treatment suspension - with no differences between the 2 treatment regimens. Percentage clinical improvement with regimen A was 92% (CI, 65-94%) versus 100% with regimen B (CI, 74-100%). The recurrence rate was 43% with regimen A and 63% with regimen B (p>0.05). None of the variables examined in the univariate logistic regression study were associated to a lesser treatment response or increased risk of recurrence of GO. CONCLUSIONS: The treatment of GO with MTPiv is safe and effective, with a lower recurrence rate when using dosing regimen A.
- Published
- 2009
11. PP373 INCIDENCE OF CATHETER RELATED INFECTION IN GASTROINTESTINAL FISTULA PATIENTS WITH TOTAL PARENTERAL NUTRITION
- Author
-
Sánchez-Ortiga, R., primary, Cordero-Cruz, A.M., additional, Valero-Zanuy, M.Á., additional, Gomis-Muñoz, P., additional, León Sanz, M., additional, and Moreno-Villares, J.M., additional
- Published
- 2010
- Full Text
- View/download PDF
12. PP370 RISK FACTORS RELATED TO THE DEVELOPMENT OF CATHETER-RELATED INFECTION IN PATIENTS WITH PARENTERAL NUTRITION FOR DIGESTIVE FISTULAE
- Author
-
Cordero-Cruz, A.M., Sanchez-Ortiga, R., Valero-Zanuy, M.Á., Gomis-Muñoz, P., Moreno-Villares, J.M., and Léon Sanz, M.
- Published
- 2010
- Full Text
- View/download PDF
13. Association between Mediterranean diet adherence and peripheral artery disease in type 2 diabetes mellitus: An observational study.
- Author
-
Zúnica-García S, Javier Blanquer-Gregori JF, Sánchez-Ortiga R, Chicharro-Luna E, and Jiménez-Trujillo MI
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Cross-Sectional Studies, Diabetic Angiopathies epidemiology, Diabetic Angiopathies prevention & control, Ankle Brachial Index, Risk Factors, Diet, Mediterranean statistics & numerical data, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 diet therapy, Diabetes Mellitus, Type 2 epidemiology, Peripheral Arterial Disease complications, Peripheral Arterial Disease epidemiology, Peripheral Arterial Disease diet therapy, Patient Compliance statistics & numerical data
- Abstract
Introduction: To evaluate the relationship between adherence to the Mediterranean diet (MD) and periphereal artery disease (PAD) in patients with type 2 diabetes mellitus (T2DM)., Methods: An observational sectional study was conducted with 174 patients diagnosed with T2DM, of which 78 patients had PAD. A patient was considered to have PAD if they obtained an ankle-brachial index (ABI) < 0.9 and/or absence of both distal pulses in one of the two feet. Data on sociodemographic and anthropometric variables, physical activity, smoking habits, biochemical blood parameters, and comorbidities were recorded. Good adherence to the MD was considered with a score ≥ 9 in MEDAS-14. Vascular factors independently associated with adherence to the MD in patients with T2DM were identified through multivariate logistic regression analysis., Results: ABI, DFU, intermittent claudication and pedal pulse absence correlated with MD adherence. DFU, intermittent claudication and posterior tibial pulse absence were associated with the final score obtained in the MEDAS-14. Nut consumption, white meat preference and sautéed dish intake were associated with PAD presence. Multivariate analysis linked MD adherence to sex (OR = 0.044, 95 % CI 0.003-0619), age (OR = 0.139, 95 % CI 0.029-0.666), duration of T2DM (OR = 7.383, 95 % CI 1.523-35.779) and age at diagnosis of T2DM (OR = 6082, 95 % IC 1.415-26.136), as well as the presence of DFU (OR = 0.000, 95 % IC 0.000-0.370) and intermittent claudication (OR = 0.004, 95 % IC 0.000-0.534)., Conclusions: Adherence to the MD is associated with a reduction in vascular complications in T2DM, highlighting its potential as a dietary intervention strategy., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
14. Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study.
- Author
-
Peral-Garrido ML, Gómez-Sabater S, Caño R, Bermúdez-García A, Lozano T, Sánchez-Ortiga R, Perdiguero M, Caro-Martínez E, Ruiz-García C, Francés R, Pascual E, and Andrés M
- Subjects
- Humans, Male, Female, Middle Aged, Aged, Prevalence, Adult, Asymptomatic Diseases, Hyperuricemia diagnostic imaging, Uric Acid analysis, Uric Acid blood, Gout diagnostic imaging, Ultrasonography
- Abstract
Background/aim: The appropriate sonographic protocol for assessing urate crystal deposits in asymptomatic hyperuricemia (AH) is undefined, as well as how the choice would impact on deposit rates and accompanying sonographic, clinical and laboratory features., Methods: Patients with AH (serum urate ≥7 mg/dL) underwent musculoskeletal ultrasound of 10 locations for OMERACT elementary gout lesions (double contour [DC] signs, tophi, aggregates). Different definitions for AH with deposits were applied, varying according to deposits (any deposits; only DC and/or tophi); gradation (any grade; only grade 2-3 deposits), location (10 locations; 4-joint scheme including knees and 1MTPs; >1 location with deposits), or pre-defined definitions (DC sign in femoral condyles/1MTP and/or tophi in 1MTP). We evaluated crystal deposits rates and compared between other sonographic features, clinical and laboratory variables., Results: Seventy-seven participants with AH showed a median 1 location (IQR 0-2) with tophi, 1 (IQR 1-2) with aggregates, and 0 locations (IQR 0-1) with DC sign. The deposition rate ranged from 23.4% (in >1 location with grade 2-3 DC or tophi) to 87.0% (in any deposit in all 10 locations). Accompanying inflammation - assessed by a positive power-Doppler (PD) signal - and erosions were found in 19.5% and 28.4% of participants, respectively. Positive PD signal was better discriminated by criteria requiring grade 2-3 or >1 location with lesions. Erosions and the different clinical and laboratory variables were similar among protocols., Conclusion: Rates of sonographic deposition in AH varied dramatically among studied protocols, while some could discriminate accompanying inflammation, all highlighting the need for a validated, consensus-based definition., Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Mariano Andrés declares speaking fees from Menarini laboratories (below $10,000). The other authors declare they have no conflict of interest in relation to this study. The authors have not received personal compensation for conducting the study nor the patients for their participation., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
15. Systemic Inflammation In Asymptomatic Hyperuricemia With Sonographic Crystal Deposits, Including A Comparison With Normouricemia And Gout.
- Author
-
Peral-Garrido ML, Gómez-Sabater S, Caño R, Bermúdez-García A, Boix P, Lozano T, Sánchez-Ortiga R, Perdiguero M, Caro-Martínez E, Ruiz-García C, Francés R, Pascual E, and Andrés M
- Abstract
Objective: To describe the inflammatory profile of asymptomatic hyperuricemia (AH) with ultrasound evidence of monosodium urate (MSU) crystals (AH-MSUpos), vs AH without deposits (AH-MSUneg), intercritical gout, and normouricemia., Methods: Based on serum urate levels, musculoskeletal ultrasound, and history of flares, we divided 122 participants into four groups: normouricemia, AH-MSUneg, AH-MSUpos, and intercritical gout. We tested four ultrasound definitions for MSU deposition in AH: grade 2-3 (G2-3) double contour and/or tophi, G1-3 double contour and/or tophi, G1-3 Stewart scheme (double contour sign in knee cartilage and/or first metatarsophalangeal joint and/or tophi in first metatarsophalangeal joint), and G2-3 Stewart scheme. Serum acute phase reactants, cytokines, pyroptosis derivates, and neutrophil-related proteins were measured and compared between groups. A linear regression model was fitted to correlate crystal and inflammatory burden (measured by ultrasound) with inflammatory markers in hyperuricemics., Results: Rates of MSU deposition in AH ranged from 26.0% to 68.8%, depending on the definition used. Levels of CRP, leukocytes, IL-1RA, IL-6, sIL-6R, IL-18, TNF-α, TGF-β, and galectin-3 were higher in hyperuricemics vs normouricemics. Sex, obesity, and comorbidity scores influenced some comparisons. We saw no differences comparing AH-MSUpos vs AH-MSUneg groups, except for higher calprotectin using G1-3 sonographic definitions and higher CRP and TGF-β when restricted to women and obese participants., Conclusions: Hyperuricemia is associated with substantial inflammation and some degree of active pyroptosis. Four different ultrasound definitions for AH with MSU deposits yielded similar findings, although we noted some differences in calprotectin, CRP, and TGF-β. Sex, obesity, and comorbidities influenced some inflammatory responses., (© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.)
- Published
- 2024
- Full Text
- View/download PDF
16. Exploring the influence of dietary habits on foot risk in type 2 diabetes patients: An observational study.
- Author
-
Zúnica-García S, Blanquer-Gregori J, Sánchez-Ortiga R, Jiménez-Trujillo MI, and Chicharro-Luna E
- Subjects
- Humans, Female, Male, Aged, Middle Aged, Risk Factors, Pilot Projects, Feeding Behavior, Patient Compliance statistics & numerical data, Surveys and Questionnaires, Ankle Brachial Index, Life Style, Diabetes Mellitus, Type 2 complications, Diabetic Foot prevention & control, Diabetic Foot etiology, Diabetic Foot epidemiology, Diet, Mediterranean statistics & numerical data
- Abstract
Background & Aim: To date, there are no studies demonstrating the impact of the Mediterranean diet on the risk of diabetic foot ulcer. The aim of this research was to examine the connection between adherence to the Mediterranean diet and the level of risk of diabetic foot ulcers in individuals with type 2 diabetes., Methods: Observational pilot study collecting sociodemographic, anthropometric, lifestyle, and type 2 diabetes-related data. Loss of protective sensation was assessed using the Semmes Weinstein 5.07-10 g monofilament, considered altered when not perceived in four points. Vascular status was assessed by palpating pulses and ankle-brachial index, indicating peripheral arterial disease if ankle-brachial index was less than 0.9 or if both pulses were absent. Foot deformities were recorded. The risk of diabetic foot ulcers was stratified into two categories: no risk and risk of diabetic foot ulcers. Adherence to the Mediterranean diet was evaluated using the Mediterranean Diet Adherence Screener-14 questionnaire (good adherence with score >7)., Results: Of the 174 patients with type 2 diabetes mellitus who participated (61.5% men and 38.5% women) with a mean age of 69.56 ± 8.86 years and a mean duration of type 2 diabetes of 15.34 ± 9.83 years. Non-adherent patients to the Mediterranean diet exhibited a higher association of diabetic foot ulcers (p = 0.030) and a lower average score on the Mediterranean Diet Adherence Screener-14 (p = 0.011). Additionally, a lower incidence of diabetic foot ulcers was observed in those who consumed nuts three or more times a week (p = 0.003) and sautéed foods two or more times a week (p = 0.003). Multivariate analysis highlighted the importance of physical activity (OR = 0.25, 95% CI 0.11-0.54; p < 0.001), podiatric treatment (OR = 2.59, 95% CI 1.21-5.56; p = 0.014), and duration of type 2 diabetes (OR = 3.25, 95% CI 1.76-5.99; p < 0.001) as significantly associated factors related to the risk of diabetic foot ulcers., Conclusions: Adhering to the Mediterranean diet correlates with a lower incidence of diabetic foot ulcers in individuals diagnosed with type 2 diabetes mellitus. Furthermore, factors such as regular physical activity, podiatric treatment, and the duration of type 2 diabetes mellitus emerge as pivotal in preventing diabetic foot ulcers., Competing Interests: Conflict of interest The authors declare that they have no competing interests., (Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
17. Concurrent corticotroph pituitary tumor and granular cell tumor: A very uncommon association.
- Author
-
López-Muñoz B, Silva Ortega S, Sánchez Ortiga R, Aranda López I, and Picó Alfonso A
- Subjects
- Adrenocorticotropic Hormone, Corticotrophs metabolism, Humans, Adenoma, Granular Cell Tumor, Pituitary Neoplasms
- Published
- 2021
- Full Text
- View/download PDF
18. Concurrent corticotroph pituitary tumor and granular cell tumor: A very uncommon association.
- Author
-
López-Muñoz B, Silva Ortega S, Sánchez Ortiga R, Aranda López I, and Picó Alfonso A
- Published
- 2020
- Full Text
- View/download PDF
19. Neurohypophyseal germinoma: hCG in cerebrospinal fluid as a key for a diagnostic challenge.
- Author
-
González-Sánchez V, Moreno-Pérez O, Sánchez-Ortiga R, Gastaldo Simeón E, and Picó Alfonso AM
- Subjects
- Adolescent, Humans, Male, Chorionic Gonadotropin cerebrospinal fluid, Germinoma cerebrospinal fluid, Germinoma diagnosis, Pituitary Neoplasms cerebrospinal fluid, Pituitary Neoplasms diagnosis
- Published
- 2013
- Full Text
- View/download PDF
20. Congenital adrenal hypoplasia and hypogonadotropic hypogonadism: phenotypic variability of the DAX-1 gene R267P mutation.
- Author
-
Sánchez-Pacheco M, Moreno-Pérez O, Sánchez-Ortiga R, Picó A, and Moreno F
- Subjects
- Adrenal Insufficiency, Humans, Hypoadrenocorticism, Familial, Infant, Male, Adrenal Hyperplasia, Congenital genetics, DAX-1 Orphan Nuclear Receptor genetics, Genetic Diseases, X-Linked genetics, Genetic Variation, Hypogonadism genetics, Mutation, Phenotype
- Published
- 2012
- Full Text
- View/download PDF
21. [Response to adjuvant therapy with potassium perchlorate in amiodarone-induced thyrotoxicosis: observations on three cases].
- Author
-
Arias N, Moreno-Pérez Ó, Boix E, Serrano J, Revert P, González VL, Sánchez-Ortiga R, and Picó AM
- Subjects
- Acenocoumarol administration & dosage, Acenocoumarol therapeutic use, Adrenergic beta-Antagonists administration & dosage, Adrenergic beta-Antagonists therapeutic use, Aged, Aged, 80 and over, Algorithms, Amiodarone therapeutic use, Atrial Fibrillation drug therapy, Cardiovascular Agents therapeutic use, Comorbidity, Dexamethasone administration & dosage, Dexamethasone therapeutic use, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Pacemaker, Artificial, Perchlorates administration & dosage, Potassium Compounds administration & dosage, Thioamides administration & dosage, Thioamides therapeutic use, Thyroid Hormones blood, Thyroidectomy, Thyrotoxicosis blood, Thyrotoxicosis chemically induced, Thyrotoxicosis surgery, Thyrotropin blood, Amiodarone adverse effects, Perchlorates therapeutic use, Potassium Compounds therapeutic use, Thyrotoxicosis drug therapy
- Abstract
Introduction: Amiodarone-induced thyrotoxicosis (AIT) is a common clinical disorder that may be life threatening and whose clinical manifestations and response to treatment may vary among patients., Methods: We present three patients treated with amiodarone for atrial fibrillation who developed AIT at least 36 months after beginning the treatment. Thyrotoxicosis worsened the underlying cardiac disorders and was resistant to treatment based on the combination of dexamethasone 8-12 mg/day i.v., thioamides 45 mg/day p.o., beta blockers and potassium perchlorate at doses of 800 to 1000 mg per day p.o. Two of the patients attained sustained euthyroidism after 12 and 32 days of combined treatment, while the third required total thyroidectomy., Conclusion: The combination of thioamides with potassium perchlorate is an appropriate form of therapy for AIT in patients resistant to thioamides. The use of this combination should be evaluated in patients with mixed AIT or AIT of unclear etiology., (Copyright © 2010 SEEN. Published by Elsevier Espana. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
22. [Rol of pituitary tumour-transforming gene (PTTG) in the pituitary adenomas].
- Author
-
Sánchez-Ortiga R, Sánchez Tejada L, Peiró Cabrera G, Moreno-Pérez O, Arias Mendoza N, Aranda López FI, and Picó Alfonso A
- Subjects
- Humans, Securin, Neoplasm Proteins genetics, Pituitary Neoplasms genetics
- Abstract
The pathogenesis of pituitary tumours is far to be understood. Pituitary transforming tumour gene (PTTG), a gen that induces aneuploidy, genetic instability, cellular proliferation and to stimulate angiogenesis, has been involved in neoplasic transformation and shown overexpressed in many neoplasm as lung, breast, endometrium, thyroid and colon malignant tumours. On the other hand, PTTG has been inconsistently studied in pituitary tumours. The majority of studies have been performed in animals and there is a great variability in the methods used in its determination. The goal of this review is to resume the role of PTTG in tumourogenesis and critically to revise the studies published in humans in order to advance in the knowledge of the pathogenesis of pituitary adenomas and to find clinical useful predictors of the behavior of these tumours., (Copyright 2010 Sociedad Española de Endocrinología y Nutrición. Published by Elsevier Espana. All rights reserved.)
- Published
- 2010
- Full Text
- View/download PDF
23. [Glioblastoma multiforme and multiple endocrine neoplasic type 2 A].
- Author
-
Sánchez-Ortiga R, Boix Carreño E, Moreno-Pérez O, and Picó Alfonso A
- Subjects
- Fatal Outcome, Humans, Male, Middle Aged, Brain Neoplasms diagnosis, Glioblastoma diagnosis, Multiple Endocrine Neoplasia Type 2a diagnosis, Neoplasms, Multiple Primary diagnosis, Thyroid Neoplasms diagnosis
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.